Cargando…
The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
Plasmodium falciparum malaria still remains a major global public health challenge with over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in sub-Saharan Africa which bears 90 % of the malaria cases. Such high P. falciparum malaria-related morbidity and mortal...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655617/ https://www.ncbi.nlm.nih.gov/pubmed/34666102 http://dx.doi.org/10.1016/j.molbiopara.2021.111425 |
_version_ | 1784612111100411904 |
---|---|
author | Mandala, Wilson L. Harawa, Visopo Dzinjalamala, Fraction Tembo, Dumizulu |
author_facet | Mandala, Wilson L. Harawa, Visopo Dzinjalamala, Fraction Tembo, Dumizulu |
author_sort | Mandala, Wilson L. |
collection | PubMed |
description | Plasmodium falciparum malaria still remains a major global public health challenge with over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in sub-Saharan Africa which bears 90 % of the malaria cases. Such high P. falciparum malaria-related morbidity and mortality rates pose a huge burden on the health and economic wellbeing of the countries affected. Lately, substantial gains have been made in reducing malaria morbidity and mortality through intense malaria control initiatives such as use of effective antimalarials, intensive distribution and use of insecticide-treated nets (ITNs), and implementation of massive indoor residual spraying (IRS) campaigns. However, these gains are being threatened by widespread resistance of the parasite to antimalarials, and the vector to insecticides. Over the years the use of vaccines has proven to be the most reliable, cost-effective and efficient method for controlling the burden and spread of many infectious diseases, especially in resource poor settings with limited public health infrastructure. Nonetheless, this had not been the case with malaria until the most promising malaria vaccine candidate, RTS,S/AS01, was approved for pilot implementation programme in three African countries in 2015. This was regarded as the most important breakthrough in the fight against malaria. However, RTS,S/AS01 has been found to have some limitations, the main ones being low efficacy in certain age groups, poor immunogenicity and need for almost three boosters to attain a reasonable efficacy. Thus, the search for a more robust and effective malaria vaccine still continues and a better understanding of naturally acquired immune responses to the various stages, including the transmissible stages of the parasite, could be crucial in rational vaccine design. This review therefore compiles what is currently known about the basic biology of P. falciparum and the natural malaria immune response against malaria and progress made towards vaccine development. |
format | Online Article Text |
id | pubmed-8655617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier/North-Holland Biomedical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86556172021-12-22 The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development Mandala, Wilson L. Harawa, Visopo Dzinjalamala, Fraction Tembo, Dumizulu Mol Biochem Parasitol Article Plasmodium falciparum malaria still remains a major global public health challenge with over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in sub-Saharan Africa which bears 90 % of the malaria cases. Such high P. falciparum malaria-related morbidity and mortality rates pose a huge burden on the health and economic wellbeing of the countries affected. Lately, substantial gains have been made in reducing malaria morbidity and mortality through intense malaria control initiatives such as use of effective antimalarials, intensive distribution and use of insecticide-treated nets (ITNs), and implementation of massive indoor residual spraying (IRS) campaigns. However, these gains are being threatened by widespread resistance of the parasite to antimalarials, and the vector to insecticides. Over the years the use of vaccines has proven to be the most reliable, cost-effective and efficient method for controlling the burden and spread of many infectious diseases, especially in resource poor settings with limited public health infrastructure. Nonetheless, this had not been the case with malaria until the most promising malaria vaccine candidate, RTS,S/AS01, was approved for pilot implementation programme in three African countries in 2015. This was regarded as the most important breakthrough in the fight against malaria. However, RTS,S/AS01 has been found to have some limitations, the main ones being low efficacy in certain age groups, poor immunogenicity and need for almost three boosters to attain a reasonable efficacy. Thus, the search for a more robust and effective malaria vaccine still continues and a better understanding of naturally acquired immune responses to the various stages, including the transmissible stages of the parasite, could be crucial in rational vaccine design. This review therefore compiles what is currently known about the basic biology of P. falciparum and the natural malaria immune response against malaria and progress made towards vaccine development. Elsevier/North-Holland Biomedical Press 2021-11 /pmc/articles/PMC8655617/ /pubmed/34666102 http://dx.doi.org/10.1016/j.molbiopara.2021.111425 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mandala, Wilson L. Harawa, Visopo Dzinjalamala, Fraction Tembo, Dumizulu The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development |
title | The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development |
title_full | The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development |
title_fullStr | The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development |
title_full_unstemmed | The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development |
title_short | The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development |
title_sort | role of different components of the immune system against plasmodium falciparum malaria: possible contribution towards malaria vaccine development |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655617/ https://www.ncbi.nlm.nih.gov/pubmed/34666102 http://dx.doi.org/10.1016/j.molbiopara.2021.111425 |
work_keys_str_mv | AT mandalawilsonl theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT harawavisopo theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT dzinjalamalafraction theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT tembodumizulu theroleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT mandalawilsonl roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT harawavisopo roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT dzinjalamalafraction roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment AT tembodumizulu roleofdifferentcomponentsoftheimmunesystemagainstplasmodiumfalciparummalariapossiblecontributiontowardsmalariavaccinedevelopment |